Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Optimizing Medication Adherence:Bictegravir/Emtricitabine/Tenofovir Alafenamide & Drug Interactions

Date: Sep 27, 2022 12:00 PM - 01:00 PM



CE Hours


CE Units


Registration closes on Oct 04, 2022 10:00 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists
  • Physicians
  • Physician Assistants
  • Nurse Practitioners


Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Joint Provider(s)

Clinical Pharmacy Associates



Registration Closed  


  • Define medication optimization as it relates to medication use and antiretroviral medication adherence
  • Highlight key aspects of Bictegravir/Emtricitabine/Tenofovir Alafenamide utilization
  • Review common mechanisms of drug-drug interactions
  • List major drug-drug interactions with Bictegravir/ Emtricitabine/Tenofovir Alafenamide
  • Discuss MTM cases involving Bictegravir/Emtricitabine/Tenofovir Alafenamide drug-drug interactions


Hope Coleman, PharmD, BCPS, AAHIVP, PharmD, BCPS
Senior Associate, Clincial Pharmacy Associates, Inc

Activity Number

Date: 09/27/22
Time: 01:00 PM - 01:00 PM

CE Hours

Registration Closed